Effect of ibopamine on peripheral haemodynamics

Area of Science:

• Pharmacology
• Cardiovascular Physiology

Background:

• Peripheral haemodynamics are crucial for cardiovascular regulation.
• Dopaminergic agonists can influence vascular function.
• Ibopamine is an orally active dopaminergic agonist.

Purpose of the Study:

• To investigate the effects of ibopamine on peripheral haemodynamics in healthy volunteers.
• To determine if a dopaminergic antagonist can counteract ibopamine's peripheral effects.

Main Methods:

• Strain gauge plethysmography was used to measure peripheral haemodynamics.
• Healthy volunteers received single or multiple oral doses of ibopamine (150 mg).
• Sulpiride (50 mg) was administered parenterally to assess its antagonistic effect.

Main Results:

• Ibopamine significantly increased arterial resting blood flow and venous capacity.
• Peripheral resistance was significantly decreased following ibopamine administration.
• Parenteral Sulpiride significantly counteracted the peripheral effects of ibopamine.
• No significant changes in heart rate or arterial blood pressure were observed.
• Ibopamine demonstrated good tolerability.

Conclusions:

• Ibopamine exerts significant effects on peripheral haemodynamics, increasing blood flow and venous capacity while reducing resistance.
• The peripheral vascular effects of ibopamine are mediated through dopaminergic pathways.
• Ibopamine is well-tolerated and does not affect central haemodynamics like heart rate or blood pressure.